Anti-Inflamatory Therapy

Recent studies demonstrate the involvement of an inflammatory process in the pathogenesis of many degenerative diseases such as Cardiac, Metabolic Syndrome, Obesity, Diabetes etc.

The metabolic syndrome can attend various pathogenic mechanisms, such as hypertension and metabolic type as oxidative stress, among others, ability to promote cytokine production, endothelial activation, increased adhesion molecules, lipid oxidation and decreased bioavailability of nitric oxide, all proatherogenic, and inflammatory phenomena.

Obesity is defined as abnormal or excessive fat accumulation in the body. It is known that obesity increases cardiovascular risk and metabolic syndrome in adults, and that inflammation plays an important role in the development of these diseases.

Until recently, adipose tissue was considered only as an energy storage tank, now known to be an active metabolic tissue that releases a number of bioactive mediators called adipokines. It is known that some of these mediators (TNF - α, IL- 6, IL - 1β) induce a low-grade systemic inflammation in persons with excess body fat.

The releases of these mediators is involved, in the metabolism of glucose, lipids, coagulation, blood pressure and muscle strength, and have been implicated in the pathology of several diseases including insulin resistance, metabolic syndrome, diabetes mellitus and in the early stages of atherogenesis.

With this background, one of the most important factors to reduce the complications associated with these diseases with chronic inflammatory processes is an anti-inflammatory and antioxidant therapy, using enzymes that block this inflammatory process without affecting other organ systems such as the digestive system.

Pharmacokinetics

The components of the various formulas reach cells, either directly or indirectly through the bloodstream. In the case of oral products, they are embedded for the same, through the various means of cellular transport, depending on the size of the molecules of the elements in question. In the case of large molecules, their incorporation into cells is by receptor-mediated endocytosis, following chain: vesicle, endosome and lisosome for smaller molecules, its incorporation will be by simple or by facilitated diffusion proteins as appropriate.

The absorption of undamaged macromolecular substances seemed impossible not long ago. However, with the advancement of highly specific methods of analysis has made it possible to verify the absorption of enzymes and other macromolecular substances from the gastrointestinal tract into the bloodstream or lymph vessels qualitatively and scientifically verifiable. In fact, a way of demonstrating that it is absorbed by the therapeutic effect achieved by its administration.

The enzymes absorbed are eliminated by the liver or by the mononuclear phagocyte system. Some studies also assumed that the absorbed enzymes could be eliminated by the pancreatic juice.

The action mechanism of the enzymes in the process of inhibiting the excessive inflammatory response contributes to the degradation of plasma proteins that invade the interstitial space during the acute phase of inflammation, which facilitates their removal from the blood or lymphatic system.

Also it seems to participate in the removal of inflammatory, such as bradykinin, that depolymerized (decomposed) and removed mediators. Finally, enzymes help to break down and remove the "mantle" fibrin formed at the site of inflammation. With this it is achieved that the inflammatory edema is reabsorbed faster, reduce its size and disappear. With this, you get a refund of the microcirculation, thus removing products is faster and more efficient, resulting in a significant decrease in the inflammation, pain and patient discomfort. It is explained that the degenerative chronic diseases including obesity, are multifactorial in origin, so it is necessary to control this subclinical inflammation to decrease the incidence of obesity and other chronic diseases.

Finally, because the proposal to control silent inflammation that precedes obesity must be comprehensive, Biocell Ultravital incorporates embryonic extracts, antioxidant enzymatic micronutrients and addition of enzymes to improve chronic inflammatory processes without risk of accumulation of toxic substances or damage to other systems such as the digestive system.

Anti-inflamatory Product

A message for life: consult your doctor regularly.
BIOCELL ULTRAVITAL Cellular Renovation Therapy
.

© 2017 Biocell Ultravital. Privacy
Like Us on Facebook Follow Us on Twitter